Saft C - Search Results

1

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.

Mai M, Akkad AD, Wieczorek S, Saft C, Andrich J, Kraus PH, Epplen JT, Arning L. Mai M, et al. Among authors: saft c. BMC Med Genet. 2006 Nov 10;7:79. doi: 10.1186/1471-2350-7-79. BMC Med Genet. 2006. PMID: 17096834 Free PMC article.

2

Assessment of complex movements reflects dysfunction in Huntington's disease.

Saft C, Andrich J, Meisel NM, Przuntek H, Müller T. Saft C, et al. J Neurol. 2003 Dec;250(12):1469-74. doi: 10.1007/s00415-003-0256-4. J Neurol. 2003. PMID: 14673581

3

Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.

Andrich J, Saft C, Arz A, Schneider B, Agelink MW, Kraus PH, Kuhn W, Müller T. Andrich J, et al. Among authors: saft c. Mov Disord. 2004 Feb;19(2):226-8. doi: 10.1002/mds.10629. Mov Disord. 2004. PMID: 14978683

4

Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.

Arning L, Jagiello P, Wieczorek S, Saft C, Andrich J, Epplen JT. Arning L, et al. Among authors: saft c. BMC Med Genet. 2004 Mar 24;5:7. doi: 10.1186/1471-2350-5-7. BMC Med Genet. 2004. PMID: 15040808 Free PMC article.

5

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.

Saft C, Zange J, Andrich J, Müller K, Lindenberg K, Landwehrmeyer B, Vorgerd M, Kraus PH, Przuntek H, Schöls L. Saft C, et al. Mov Disord. 2005 Jun;20(6):674-9. doi: 10.1002/mds.20373. Mov Disord. 2005. PMID: 15704211

6

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.

Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT. Arning L, et al. Among authors: saft c. Neurogenetics. 2005 Feb;6(1):25-8. doi: 10.1007/s10048-004-0198-8. Epub 2004 Nov 17. Neurogenetics. 2005. PMID: 15742215

7

Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD).

Arning L, Kraus PH, Saft C, Andrich J, Epplen JT. Arning L, et al. Among authors: saft c. BMC Med Genet. 2005 Oct 3;6:35. doi: 10.1186/1471-2350-6-35. BMC Med Genet. 2005. PMID: 16202123 Free PMC article.

8

[Amisulpride in Huntington's disease].

Saft C, Andrich J, Kraus PH, Przuntek H. Saft C, et al. Psychiatr Prax. 2005 Oct;32(7):363-6. doi: 10.1055/s-2003-815024. Psychiatr Prax. 2005. PMID: 16220421 German.

9

Is the retina affected in Huntington disease?

Petrasch-Parwez E, Saft C, Schlichting A, Andrich J, Napirei M, Arning L, Wieczorek S, Dermietzel R, Epplen JT. Petrasch-Parwez E, et al. Among authors: saft c. Acta Neuropathol. 2005 Nov;110(5):523-5. doi: 10.1007/s00401-005-1092-7. Epub 2005 Oct 13. Acta Neuropathol. 2005. PMID: 16222522 No abstract available.

10

Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.

Hansen W, Saft C, Andrich J, Müller T, Wieczorek S, Epplen JT, Arning L. Hansen W, et al. Among authors: saft c. J Negat Results Biomed. 2005 Dec 22;4:12. doi: 10.1186/1477-5751-4-12. J Negat Results Biomed. 2005. PMID: 16372906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters